Supernus Pharmaceuticals Inc (SUPN)
Operating Cash Flow Growth
-108.22%
Quarterly · Period ending:
SUPN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-108.22%period ending
Latest reported-108.22%period ending
SUPN Quarterly Cash from Operations YoY % (-25.04% → -108.22%)
Year-over-year change
High-resolution chart · PNG
SUPN operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -108.2173% | |
| 117.4058% | |
| -55.2741% | |
| -215.2167% | |
| 64.3134% | |
| -20.3172% | |
| -1.2278% | |
| 49.1847% | |
| 288.7464% | |
| -21.8316% | |
| 63.104% | |
| 159.1937% | |
| -126.5386% | |
| 1,041.934% | |
| -43.4735% | |
| 436.764% | |
| 53.6911% | |
| -88.116% | |
| 52.7041% | |
| -173.406% | |
| -49.6754% | |
| 306.0117% | |
| -27.0786% | |
| -85.132% | |
| 220.5319% | |
| -72.9761% | |
| 33.31% | |
| -39.697% | |
| 337.5686% | |
| 21.5973% | |
| -9.5941% | |
| 60.1026% | |
| -74.7282% | |
| 103.1217% | |
| 45.7013% | |
| 38.1246% | |
| 54.6284% | |
| 525.1432% | |
| 25.1028% | |
| 1,046.6644% | |
| 14.3704% | |
| -724.6521% | |
| 185.0157% | |
| -111.1377% | |
| 311.3689% | |
| 102.633% | |
| 174.2384% | |
| 272.2379% | |
| 55.9505% | |
| -10.9214% | |
| 41.6295% | |
| -37.5863% | |
| -62.6071% | |
| -71.0667% | |
| -96.3265% | |
| -23.6678% | |
| -7.3692% | |
| -2.7242% | |
| 29.7605% | |
| -25.0423% |